Guardant Health Receives Expanded Medicare Coverage for Guardant360 Across the Vast Majority of Solid Tumor Cancers

    NEXT STORY
    Jounce Therapeutics to Present New Data on a Potential Predictive Biomarker from the Vopratelimab ICONIC Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting
    PREV STORY
    BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medicaid Expansion Could Harm Rural Healthcare, States Association of American Physicians and Surgeons (AAPS)

    TUCSON, Ariz., Sept. 28, 2018 (GLOBE NEWSWIRE) -- Medicaid expansion is on the November ...

    author_avatar
    NASDAQ Market News

    Aileron Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights

    author_avatar
    NASDAQ Market News

    Project HOPE Team Responds to Local Health Needs from Hurricane Harvey

    Millwood, VA, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Project HOPE has deployed an expert ...

    author_avatar
    NASDAQ Market News